Biosimilars LatAm - Mexico 2023

At Camino Real Polanco in Mexico City on November 15 & 16

Mexico is making proactive and systematic strides towards shaping the future of the pharmaceutical industry within the country and ambitiously across the entire region.

The Estrategia de Certidumbre Regulatoria 2022-2030 (Regulatory Certainty Strategy) was recently presented by COFEPRIS. This well-defined strategy ultimately aims to enhance access to therapies in Latin America. This strategy recognizes the need for local market growth and emphasizes the importance of fostering interconnections within the region, across the continent, and globally.

The Mexican edition of the forum highlights investment as a crucial catalyst for promising growth, elucidates the investment sector's interests and concerns, and provides proactive measures to navigate the upcoming COFEPRIS-defined scenario effectively.